|
| Press Releases |
|
 |
|
| Saturday, August 24, 2024 |
|
|
Ministry of Health, Labour and Welfare in Japan Approves Partial Change Application for Moderna's COVID-19 mRNA Vaccine Targeting SARS-COV-2 Variant JN.1 |
| Moderna, Inc. (NASDAQ:MRNA) today announced that it has received approval from the Ministry of Health, Labour and Welfare (MHLW) in Japan for a partial change application for an updated formulation of its COVID-19 mRNA vaccine Spikevax, targeting the SARS-CoV-2 variant JN.1. more info >> |
|
| Tuesday, March 26, 2024 |
|
|
Moderna Achieves Positive Interim Results from Phase 3 Trial of Next-Generation COVID-19 Vaccine |
| Moderna, Inc. (NASDAQ:MRNA) today announced that mRNA-1283, the Company's next-generation COVID-19 vaccine, has successfully met the primary endpoints of its Phase 3 clinical trial, demonstrating a higher immune response against SARS-CoV-2 when compared to mRNA-1273.222, Moderna's licensed COVID-19 vaccine. more info >> |
|
| Monday, December 11, 2023 |
|
|
Moderna Reviews its Environmental, Social and Governance (ESG) Progress and Ambitions at Second ESG Investor Event |
| more info >> |
|
| Wednesday, July 5, 2023 |
|
|
Moderna Announces Global Regulatory Submissions for Its Respiratory Syncytial Virus (RSV) Vaccine, MRNA-1345 |
| Moderna, Inc. (Nasdaq:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today provided an update on regulatory submissions for mRNA-1345, a vaccine for the prevention of RSV-associated lower respiratory tract disease (RSV-LRTD) and acute respiratory disease (ARD) in adults aged 60 years or older. more info >> |
|
| Wednesday, May 3, 2023 |
|
|
Moderna Announces Establishment of an Enterprise Solutions Hub and Commercial Operations in The Philippines |
| Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced plans to establish an Enterprise Solutions Hub in the Philippines. The Moderna Enterprise Solutions Hub will provide business services across the Asia Pacific region, where Moderna currently has operations in six markets. Moderna also plans to establish commercial operations in the Philippines. more info >> |
|
| Tuesday, September 13, 2022 |
|
|
Indonesia's Bio Farma ready to produce IndoVac Covid-19 vaccines |
| PT Bio Farma, the holding company for state-owned pharmaceutical companies in Indonesia, announced a new milestone in manufacturing IndoVac, a Covid-19 vaccine brand it has developed since November 2021. more info >> |
|
| Friday, September 9, 2022 |
|
|
Indonesian pharmaceutical Bio Farma ready to produce IndoVac Covid-19 vaccines |
| PT Bio Farma, the holding company for state-owned pharmaceutical companies in Indonesia, announced a new milestone in the manufacturing process of IndoVac, a Covid-19 vaccine brand it has developed since November 2021. more info >> |
|
| Tuesday, July 19, 2022 |
|
|
Therapeutic Goods Administration Grants Provisional Approval for Moderna's COVID-19 Vaccine in Children Aged Six Months to Five Years |
| Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the Therapeutic Goods Administration (TGA) in Australia has granted provisional registration for the use of Moderna's mRNA COVID-19 vaccine, Spikevax, in a two-dose series of 25 ug per dose for active immunization to prevent COVID-19 caused by SARS-CoV-2 in children aged 6 months to 5 years. more info >> |
|
| Thursday, February 17, 2022 |
|
|
Therapeutic Goods Administration of Australia Authorizes Moderna's Covid-19 Vaccine in Children (6-11 Years) |
| Moderna, Inc., (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the Therapeutic Goods Administration (TGA) in Australia has granted provisional registration for the use of Moderna's mRNA COVID-19 vaccine, Spikevax, in a 50 ug dose, two-dose series, for active immunization to prevent COVID-19 caused by SARS-CoV-2 in children aged 6-11 years. more info >> |
|
| Wednesday, February 16, 2022 |
|
|
Moderna Announces Plan to Expand Footprint in Asia with Four Additional Subsidiaries |
| Moderna, Inc., (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced plans to expand its commercial network across Asia with the addition of four new subsidiaries in Malaysia, Taiwan, Singapore, and Hong Kong. This expansion comes as the Company continues to scale up the manufacturing and distribution of its COVID-19 vaccine and future mRNA vaccines and therapeutics. more info >> |
|
|
|
|
|
|
|
|
 |
| Latest Press Releases |
|
NEFECON(R) Included in National Reimbursement Drug List (NRDL)
Nov 29, 2024 22:45 HKT/SGT
|
|
|
Niyo Doubles Click-Through Rates and Improves Customer Retention with CleverTap 
Nov 29, 2024 22:40 HKT/SGT
|
|
|
Dmall Inc. Announces Proposed Listing on the Main Board of the Hong Kong Stock Exchange
Nov 29, 2024 22:30 HKT/SGT
|
|
|
Edvantage Group Announces FY2024 Annual Results
Nov 29, 2024 22:14 HKT/SGT
|
|
|
The Hong Kong Institute of Directors Announces Winners
Nov 29, 2024 21:06 HKT/SGT
|
|
|
Launch of Demonstration Test for CO2 Capture from Chemical Recovery Boilers at Paper Mills in Japan
Nov 29, 2024 19:11 JST
|
|
|
Mitsubishi Electric's Swedish Subsidiary Signs a Share Transfer Agreement to Wholly Acquire Norwegian Elevator Company ALT Heis
Nov 29, 2024 15:30 JST
|
|
|
JAL and NEC Test AI-Powered Carry-On Baggage Analysis Solution
Nov 29, 2024 15:27 JST
|
|
|
Hitachi Energy to integrate ScottishPower wind farm to power almost one million homes in the United Kingdom
Nov 29, 2024 12:54 JST
|
|
|
TGR Announces Partially Upgraded Supra (3.0-liter) and Special-edition Supra "A90 Final Edition"
Nov 29, 2024 11:22 JST
|
|
|
HEROWORKS Intensifies Collaboration with a Global Hotel IT Company
Nov 29, 2024 10:00 HKT/SGT
|
|
|
EdgePoint Infrastructure Inks Strategic Partnership with CelcomDigi to expand connectivity in Malaysia at TowerXchange Meet Up Asia 2024
Nov 29, 2024 09:30 HKT/SGT
|
|
|
Trescon's World Blockchain Summit Rebrands to HODL, Signalling a Bold New Era for Innovations in Blockchain and Beyond
Nov 28, 2024 23:26 HKT/SGT
|
|
|
Academic Labs (AAX) Selected as the Official Educational Sponsor for the 2024 World Chess Championship in Singapore
Nov 28, 2024 21:50 HKT/SGT
|
|
|
Hitachi Receives an Order for All 147 Elevators and Escalators for the Second Phase of the Taipei MRT Wanda-Zhonghe-Shulin Line
Nov 28, 2024 22:20 JST
|
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|
